GLP-1 medicines are also efficacious in obstructive sleep apnea (OSA), a respiratory disorder that contributes to chronic inflammation and increases the risk of cardiometabolic diseases. The gene discussed is GLP1R; the disease is obstructive sleep apnea syndrome.